Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

• Fabio Vieira Teixeira,
• Rogerio Serafim Parra,
• Omar Feres,
• Paulo Gustavo Kotze

Affiliations

Fabio Vieira Teixeira

Rogerio Serafim Parra

Omar Feres

Paulo Gustavo Kotze